Pharmaceutical Companies to Blame for Out-of-Control Prices for Life-Saving Drug During tonight’s State of the Union address, President Trump is expected to address the mounting crisis of affordability caused by the out-of-control price of prescription drugs. One drug in particular has been at the forefront of this crisis for millions of Americans diagnosed with […]
Comprehensive Effort Will Target D.C., In Addition To Nine Presidential & Senate Battleground States Calling For Passage of Bipartisan Solutions to Lower Prescription Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) announced Tuesday the start of a comprehensive, seven-figure campaign targeting Washington, D.C., in addition to nine presidential and Senate battleground states, […]
Congressional Action Needed to Shine a Light on Big Pharma’s Egregious Pricing Tactics & Hold the Industry Accountable In yet another example of the lengths Big Pharma will go to evade responsibility and keep prices high, a new analysis from Bloomberg Law reveals that efforts to reign in out-of-control prescription drug prices on the state-level […]
Trump Can Use Platform To Demand Congress Hold Big Pharma Accountable & Deliver Relief For Americans Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) said Monday that President Trump will have a unique opportunity during the 2020 State of the Union address to advance his commitment to lowering prescription drug prices – by […]
Brand Name Drug Giant Beats Wall Street Expectations After Price Hikes on Treatments for Osteoporosis, Heart Conditions and Cancer Yet another Big Pharma giant proved what we already know – that hiking prices on American patients continues to be a profitable practice for the pharmaceutical industry. On Thursday, brand name drug company Amgen announced it […]
Brand Name Giants Keep Good Times Rolling Thanks to Series of Price Hikes on American Patients New fourth quarter earnings reports released this week from brand name giants Eli Lilly, Roche, Novartis and Pfizer demonstrate that out-of-control prescription drug prices paired with repeated price hikes continue to support big time profits for Big Pharma. All […]
Prescription Drug Price Hikes Help Fuel Massive 32 Percent Boost to Profits For Big Pharma Giant As millions of Americans struggle to afford the medications they need, the first earnings report from a Big Pharma giant demonstrates the industry continues to rake in sky-high profits by shamelessly hiking prices. Just yesterday, brand name drug […]
Lawmakers Hold Strong, Advance Trade Deal Without Big Pharma-Backed Provision on Biologic Exclusivity Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) applauded U.S. Senators Thursday who voted to approve the revised U.S.-Mexico-Canada Agreement (USMCA) without a provision that would have helped brand name drug companies undermine competition and keep prices high for American […]
Editorial Boards, Lawmakers and More Reiterate Need for Market-Based Solutions to Out-of-Control Prescription Drug Prices in 2020 Right on cue, Big Pharma kicked off the New Year by raising prices on 2,167 prescription drugs in the first week of 2020. The new round of price hikes have added to the momentum to pass bipartisan market-based […]
News from First Weeks of New Year Underscores Urgent Need for Action in Congress In case you missed it, Big Pharma has hiked prices on 2,167 prescription drugs so far this year – proving once again that without legislative action, brand name drug makers will continue to price-gouge American patients. Among the companies hiking prices […]